Pharmaceutical Market in Denmark 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	186 Pages	TechNavio	March, 2025	INF19898918

Best Price Guarantee
Price	from $2,500
Length	186 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19898918

Pharmaceutical Market In Denmark 2025-2029

The pharmaceutical market in denmark is forecasted to grow by USD 843.4 mn during 2024-2029, accelerating at a CAGR of 3.5% during the forecast period. The report on the pharmaceutical market in denmark provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, growing prevalence of chronic conditions in denmark, and increasing geriatric population in denmark.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's pharmaceutical market in denmark is segmented as below:

By Class Type

Musculoskeletal system
Nervous system
Respiratory system
Others

By Distribution Channel

Offline
Online

By Type

Prescription drugs
OTC drugs

By Drug Class

Branded drugs
Generic drugs

By Sector

Primary sector
Hospital sector

By Geographical Landscape

Europe

This study identifies the high demand for personalized medicines as one of the prime reasons driving the pharmaceutical market in denmark growth during the next few years. Also, digital health integration in pharmaceutical market in denmark and heightened focus on research and development for rare diseases will lead to sizable demand in the market.

The report on the pharmaceutical market in denmark covers the following areas:

Pharmaceutical Market in Denmark sizing
Pharmaceutical Market in Denmark forecast
Pharmaceutical Market in Denmark industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical market in denmark vendors that include Abblo Pharma, ALK Abello AS, AstraZeneca Plc, Biogen Inc., DanCann Pharma AS, F. Hoffmann La Roche Ltd., Ferring BV, GlaxoSmithKline Plc, H Lundbeck AS, LEO Pharma AS, Novo Nordisk AS, ORIFARM GROUP AS, Orion Corp., Pfizer Inc., Sandoz Group AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., UCB SA, and Vifor Pharma Management Ltd.. Also, the pharmaceutical market in denmark analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Class Type; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Drug Class; Executive Summary - Chart on Market Segmentation by Sector; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Denmark - Market size and forecast 2024-2029 ($ million); Data Table on Denmark - Market size and forecast 2024-2029 ($ million); Chart on Denmark: Year-over-year growth 2024-2029 (%); Data Table on Denmark: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Pharmaceutical Market in Denmark 2019 - 2023; Historic Market Size - Data Table on Pharmaceutical Market in Denmark 2019 - 2023 ($ million); 5.2 Class Type segment analysis 2019 - 2023; Historic Market Size - Class Type Segment 2019 - 2023 ($ million); 5.3 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.4 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.5 Drug Class segment analysis 2019 - 2023; Historic Market Size - Drug Class Segment 2019 - 2023 ($ million); 5.6 Sector segment analysis 2019 - 2023; Historic Market Size - Sector Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on pharmaceutical market in Denmark
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Class Type: 8.1 Market segments; Chart on Class Type - Market share 2024-2029 (%); Data Table on Class Type - Market share 2024-2029 (%); 8.2 Comparison by Class Type; Chart on Comparison by Class Type; Data Table on Comparison by Class Type; 8.3 Musculoskeletal system - Market size and forecast 2024-2029; Chart on Musculoskeletal system - Market size and forecast 2024-2029 ($ million); Data Table on Musculoskeletal system - Market size and forecast 2024-2029 ($ million); Chart on Musculoskeletal system - Year-over-year growth 2024-2029 (%); Data Table on Musculoskeletal system - Year-over-year growth 2024-2029 (%); 8.4 Nervous system - Market size and forecast 2024-2029; Chart on Nervous system - Market size and forecast 2024-2029 ($ million); Data Table on Nervous system - Market size and forecast 2024-2029 ($ million); Chart on Nervous system - Year-over-year growth 2024-2029 (%); Data Table on Nervous system - Year-over-year growth 2024-2029 (%); 8.5 Respiratory system - Market size and forecast 2024-2029; Chart on Respiratory system - Market size and forecast 2024-2029 ($ million); Data Table on Respiratory system - Market size and forecast 2024-2029 ($ million); Chart on Respiratory system - Year-over-year growth 2024-2029 (%); Data Table on Respiratory system - Year-over-year growth 2024-2029 (%); 8.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Class Type; Market opportunity by Class Type ($ million); Data Table on Market opportunity by Class Type ($ million)
9 Market Segmentation by Distribution Channel: 9.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 9.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 9.3 Offline - Market size and forecast 2024-2029; Chart on Offline - Market size and forecast 2024-2029 ($ million); Data Table on Offline - Market size and forecast 2024-2029 ($ million); Chart on Offline - Year-over-year growth 2024-2029 (%); Data Table on Offline - Year-over-year growth 2024-2029 (%); 9.4 Online - Market size and forecast 2024-2029; Chart on Online - Market size and forecast 2024-2029 ($ million); Data Table on Online - Market size and forecast 2024-2029 ($ million); Chart on Online - Year-over-year growth 2024-2029 (%); Data Table on Online - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Type: 10.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 10.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 10.3 Prescription drugs - Market size and forecast 2024-2029; Chart on Prescription drugs - Market size and forecast 2024-2029 ($ million); Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ million); Chart on Prescription drugs - Year-over-year growth 2024-2029 (%); Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%); 10.4 OTC drugs - Market size and forecast 2024-2029; Chart on OTC drugs - Market size and forecast 2024-2029 ($ million); Data Table on OTC drugs - Market size and forecast 2024-2029 ($ million); Chart on OTC drugs - Year-over-year growth 2024-2029 (%); Data Table on OTC drugs - Year-over-year growth 2024-2029 (%); 10.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
11 Market Segmentation by Drug Class: 11.1 Market segments; Chart on Drug Class - Market share 2024-2029 (%); Data Table on Drug Class - Market share 2024-2029 (%); 11.2 Comparison by Drug Class; Chart on Comparison by Drug Class; Data Table on Comparison by Drug Class; 11.3 Branded drugs - Market size and forecast 2024-2029; Chart on Branded drugs - Market size and forecast 2024-2029 ($ million); Data Table on Branded drugs - Market size and forecast 2024-2029 ($ million); Chart on Branded drugs - Year-over-year growth 2024-2029 (%); Data Table on Branded drugs - Year-over-year growth 2024-2029 (%); 11.4 Generic drugs - Market size and forecast 2024-2029; Chart on Generic drugs - Market size and forecast 2024-2029 ($ million); Data Table on Generic drugs - Market size and forecast 2024-2029 ($ million); Chart on Generic drugs - Year-over-year growth 2024-2029 (%); Data Table on Generic drugs - Year-over-year growth 2024-2029 (%); 11.5 Market opportunity by Drug Class; Market opportunity by Drug Class ($ million); Data Table on Market opportunity by Drug Class ($ million)
12 Market Segmentation by Sector: 12.1 Market segments; Chart on Sector - Market share 2024-2029 (%); Data Table on Sector - Market share 2024-2029 (%); 12.2 Comparison by Sector; Chart on Comparison by Sector; Data Table on Comparison by Sector; 12.3 Primary sector - Market size and forecast 2024-2029; Chart on Primary sector - Market size and forecast 2024-2029 ($ million); Data Table on Primary sector - Market size and forecast 2024-2029 ($ million); Chart on Primary sector - Year-over-year growth 2024-2029 (%); Data Table on Primary sector - Year-over-year growth 2024-2029 (%); 12.4 Hospital sector - Market size and forecast 2024-2029; Chart on Hospital sector - Market size and forecast 2024-2029 ($ million); Data Table on Hospital sector - Market size and forecast 2024-2029 ($ million); Chart on Hospital sector - Year-over-year growth 2024-2029 (%); Data Table on Hospital sector - Year-over-year growth 2024-2029 (%); 12.5 Market opportunity by Sector; Market opportunity by Sector ($ million); Data Table on Market opportunity by Sector ($ million)
13 Customer Landscape: 13.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
14 Drivers, Challenges, and Opportunity/Restraints: 14.1 Market drivers; 14.2 Market challenges; 14.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 14.4 Market opportunities/restraints
15 Competitive Landscape: 15.1 Overview; 15.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 15.3 Landscape disruption; Overview on factors of disruption; 15.4 Industry risks; Impact of key risks on business
16 Competitive Analysis: 16.1 Companies profiled; Companies covered; 16.2 Company ranking index; Company ranking index; 16.3 Market positioning of companies; Matrix on companies position and classification; 16.4 ALK Abello AS; ALK Abello AS - Overview; ALK Abello AS - Product / Service; ALK Abello AS - Key offerings; SWOT; 16.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 16.6 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 16.7 Ferring BV; Ferring BV - Overview; Ferring BV - Product / Service; Ferring BV - Key news; Ferring BV - Key offerings; SWOT; 16.8 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 16.9 H Lundbeck AS; H Lundbeck AS - Overview; H Lundbeck AS - Product / Service; H Lundbeck AS - Key offerings; SWOT; 16.10 LEO Pharma AS; LEO Pharma AS - Overview; LEO Pharma AS - Product / Service; LEO Pharma AS - Key offerings; SWOT; 16.11 Novo Nordisk AS; Novo Nordisk AS - Overview; Novo Nordisk AS - Business segments; Novo Nordisk AS - Key offerings; Novo Nordisk AS - Segment focus; SWOT; 16.12 ORIFARM GROUP AS; ORIFARM GROUP AS - Overview; ORIFARM GROUP AS - Product / Service; ORIFARM GROUP AS - Key offerings; SWOT; 16.13 Orion Corp.; Orion Corp. - Overview; Orion Corp. - Product / Service; Orion Corp. - Key offerings; SWOT; 16.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 16.15 Sandoz Group AG; Sandoz Group AG - Overview; Sandoz Group AG - Product / Service; Sandoz Group AG - Key offerings; SWOT; 16.16 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT; 16.17 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 16.18 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; SWOT
17 Appendix: 17.1 Scope of the report; 17.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 17.3 Currency conversion rates for US$; Currency conversion rates for US$; 17.4 Research methodology; Research methodology; 17.5 Data procurement; Information sources; 17.6 Data validation; Data validation; 17.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 17.8 Data synthesis; Data synthesis; 17.9 360 degree market analysis; 360 degree market analysis; 17.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Class Type; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class; Exhibits8: Executive Summary - Chart on Market Segmentation by Sector; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Denmark - Market size and forecast 2024-2029 ($ million); Exhibits21: Data Table on Denmark - Market size and forecast 2024-2029 ($ million); Exhibits22: Chart on Denmark: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Denmark: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Pharmaceutical Market in Denmark 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Class Type Segment 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Sector Segment 2019 - 2023 ($ million); Exhibits30: Five forces analysis - Comparison between 2024 and 2029; Exhibits31: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits32: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits33: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits34: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits35: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits36: Chart on Market condition - Five forces 2024 and 2029; Exhibits37: Chart on Class Type - Market share 2024-2029 (%); Exhibits38: Data Table on Class Type - Market share 2024-2029 (%); Exhibits39: Chart on Comparison by Class Type; Exhibits40: Data Table on Comparison by Class Type; Exhibits41: Chart on Musculoskeletal system - Market size and forecast 2024-2029 ($ million); Exhibits42: Data Table on Musculoskeletal system - Market size and forecast 2024-2029 ($ million); Exhibits43: Chart on Musculoskeletal system - Year-over-year growth 2024-2029 (%); Exhibits44: Data Table on Musculoskeletal system - Year-over-year growth 2024-2029 (%); Exhibits45: Chart on Nervous system - Market size and forecast 2024-2029 ($ million); Exhibits46: Data Table on Nervous system - Market size and forecast 2024-2029 ($ million); Exhibits47: Chart on Nervous system - Year-over-year growth 2024-2029 (%); Exhibits48: Data Table on Nervous system - Year-over-year growth 2024-2029 (%); Exhibits49: Chart on Respiratory system - Market size and forecast 2024-2029 ($ million); Exhibits50: Data Table on Respiratory system - Market size and forecast 2024-2029 ($ million); Exhibits51: Chart on Respiratory system - Year-over-year growth 2024-2029 (%); Exhibits52: Data Table on Respiratory system - Year-over-year growth 2024-2029 (%); Exhibits53: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits54: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits55: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits56: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits57: Market opportunity by Class Type ($ million); Exhibits58: Data Table on Market opportunity by Class Type ($ million); Exhibits59: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits60: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits61: Chart on Comparison by Distribution Channel; Exhibits62: Data Table on Comparison by Distribution Channel; Exhibits63: Chart on Offline - Market size and forecast 2024-2029 ($ million); Exhibits64: Data Table on Offline - Market size and forecast 2024-2029 ($ million); Exhibits65: Chart on Offline - Year-over-year growth 2024-2029 (%); Exhibits66: Data Table on Offline - Year-over-year growth 2024-2029 (%); Exhibits67: Chart on Online - Market size and forecast 2024-2029 ($ million); Exhibits68: Data Table on Online - Market size and forecast 2024-2029 ($ million); Exhibits69: Chart on Online - Year-over-year growth 2024-2029 (%); Exhibits70: Data Table on Online - Year-over-year growth 2024-2029 (%); Exhibits71: Market opportunity by Distribution Channel ($ million); Exhibits72: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits73: Chart on Type - Market share 2024-2029 (%); Exhibits74: Data Table on Type - Market share 2024-2029 (%); Exhibits75: Chart on Comparison by Type; Exhibits76: Data Table on Comparison by Type; Exhibits77: Chart on Prescription drugs - Market size and forecast 2024-2029 ($ million); Exhibits78: Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ million); Exhibits79: Chart on Prescription drugs - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on OTC drugs - Market size and forecast 2024-2029 ($ million); Exhibits82: Data Table on OTC drugs - Market size and forecast 2024-2029 ($ million); Exhibits83: Chart on OTC drugs - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on OTC drugs - Year-over-year growth 2024-2029 (%); Exhibits85: Market opportunity by Type ($ million); Exhibits86: Data Table on Market opportunity by Type ($ million); Exhibits87: Chart on Drug Class - Market share 2024-2029 (%); Exhibits88: Data Table on Drug Class - Market share 2024-2029 (%); Exhibits89: Chart on Comparison by Drug Class; Exhibits90: Data Table on Comparison by Drug Class; Exhibits91: Chart on Branded drugs - Market size and forecast 2024-2029 ($ million); Exhibits92: Data Table on Branded drugs - Market size and forecast 2024-2029 ($ million); Exhibits93: Chart on Branded drugs - Year-over-year growth 2024-2029 (%); Exhibits94: Data Table on Branded drugs - Year-over-year growth 2024-2029 (%); Exhibits95: Chart on Generic drugs - Market size and forecast 2024-2029 ($ million); Exhibits96: Data Table on Generic drugs - Market size and forecast 2024-2029 ($ million); Exhibits97: Chart on Generic drugs - Year-over-year growth 2024-2029 (%); Exhibits98: Data Table on Generic drugs - Year-over-year growth 2024-2029 (%); Exhibits99: Market opportunity by Drug Class ($ million); Exhibits100: Data Table on Market opportunity by Drug Class ($ million); Exhibits101: Chart on Sector - Market share 2024-2029 (%); Exhibits102: Data Table on Sector - Market share 2024-2029 (%); Exhibits103: Chart on Comparison by Sector; Exhibits104: Data Table on Comparison by Sector; Exhibits105: Chart on Primary sector - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on Primary sector - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on Primary sector - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Primary sector - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Hospital sector - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on Hospital sector - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on Hospital sector - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Hospital sector - Year-over-year growth 2024-2029 (%); Exhibits113: Market opportunity by Sector ($ million); Exhibits114: Data Table on Market opportunity by Sector ($ million); Exhibits115: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits116: Impact of drivers and challenges in 2024 and 2029; Exhibits117: Overview on criticality of inputs and factors of differentiation; Exhibits118: Overview on factors of disruption; Exhibits119: Impact of key risks on business; Exhibits120: Companies covered; Exhibits121: Company ranking index; Exhibits122: Matrix on companies position and classification; Exhibits123: ALK Abello AS - Overview; Exhibits124: ALK Abello AS - Product / Service; Exhibits125: ALK Abello AS - Key offerings; Exhibits126: SWOT; Exhibits127: AstraZeneca Plc - Overview; Exhibits128: AstraZeneca Plc - Product / Service; Exhibits129: AstraZeneca Plc - Key news; Exhibits130: AstraZeneca Plc - Key offerings; Exhibits131: SWOT; Exhibits132: F. Hoffmann La Roche Ltd. - Overview; Exhibits133: F. Hoffmann La Roche Ltd. - Business segments; Exhibits134: F. Hoffmann La Roche Ltd. - Key news; Exhibits135: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits136: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits137: SWOT; Exhibits138: Ferring BV - Overview; Exhibits139: Ferring BV - Product / Service; Exhibits140: Ferring BV - Key news; Exhibits141: Ferring BV - Key offerings; Exhibits142: SWOT; Exhibits143: GlaxoSmithKline Plc - Overview; Exhibits144: GlaxoSmithKline Plc - Business segments; Exhibits145: GlaxoSmithKline Plc - Key news; Exhibits146: GlaxoSmithKline Plc - Key offerings; Exhibits147: GlaxoSmithKline Plc - Segment focus; Exhibits148: SWOT; Exhibits149: H Lundbeck AS - Overview